Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Ledger.
Press releases published on June 2, 2025

COS Systems expands Open Access Services partnership with Fujitsu
Extended partnership enables turn-key Open Access network operations backed by COS Business Engine. WEST PALM BEACH, FL, UNITED STATES, June 1, 2025 /EINPresswire.com/ -- COS Systems continues to strengthen its partnership with Fujitsu, a leading …

Biognosys stellt Spectronaut 20 und SpectroMine 5 vor und setzt damit neue Maßstäbe in der Immunopeptidomik
ZÜRICH und BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, ein weltweit führender Anbieter von massenspektrometriebasierten Proteomiklösungen, gibt die Einführung von Spectronaut® 20 und SpectroMine™ 5 auf der ASMS 2025 Annual Conference bekannt, die …

Biognosys lanza Spectronaut 20 y SpectroMine 5, estableciendo un nuevo hito en la inmunopeptidómica
ZÚRICH y BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, líder mundial en soluciones de proteómica basadas en espectrometría de masas, ha anunciado el lanzamiento de Spectronaut® 20 y SpectroMine™ 5 en la convención anual ASMS de 2025, que tendrá …

Biognosys lance Spectronaut 20 et SpectroMine 5, établissant de nouvelles références en immunopeptidomique
ZURICH et BOSTON, 02 juin 2025 (GLOBE NEWSWIRE) -- Biognosys, leader mondial des solutions de protéomique basées sur la spectrométrie de masse, annonce le lancement de Spectronaut® 20 et SpectroMine™ 5 lors de la conférence annuelle ASMS 2025, qui se …

Biognosys lancia Spectronaut 20 e SpectroMine 5 e stabilisce nuovi parametri di riferimento nell'immunopeptidomica
ZURIGO e BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, leader mondiale nelle soluzioni di proteomica basate sulla spettrometria di massa, annuncia il lancio di Spectronaut® 20 e SpectroMine™ 5 alla Conferenza annuale dell'American Society for Mass …

Biognosys zet toon in immunopeptidomics met Spectronaut 20 en SpectroMine 5
ZURICH en BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Tijdens de ASMS 2025 Annual Conference, die van 1 tot 5 juni wordt gehouden in Baltimore, presenteert Biognosys, een internationale koploper in proteomica-oplossingen op basis van massaspectrometrie, …

HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …